cro.directory
← Compare landing

TATAA Biocenter vs uBriGene

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/tataa-biocenter/ubrigene

CategoryTATAA BiocenteruBriGene
Listed sitecroboth
SummaryGLP- and GCLP-compliant molecular CRO specializing in bioanalysis for gene therapy, RNA therapeutics, and advanced modalities, offering qPCR, NGS, and plasma proteomics services since 2001.uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.
Services
  • Biomarker Assays
  • Bioanalysis
  • Genomics & Sequencing Services
  • Proteomics Services
  • Translational Research
  • Analytical Method Development & Validation
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
Modalities
  • Gene Therapy
  • Cell Therapy
  • mRNA
  • Oligonucleotide
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
IndicationsData not yet provided.
  • Oncology
Locations
  • Headquarters, Gothenburg, Västra Götaland, Sweden
  • Headquarters, Maryland, Maryland, USA
  • Boston, Boston, Massachusetts, USA
  • Worcester, Worcester, Massachusetts, USA
Certifications
  • SWEDAC · Identifier: GLP-accredited for qPCR, dPCR, and molecular biology
  • ISO/IEC · Identifier: ISO/IEC 17025-compliant
  • FDA · Identifier: 20+ INDs filed and accepted
  • EMA · Identifier: 20+ INDs filed and accepted
  • NMPA · Identifier: 20+ INDs filed and accepted
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.